New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma
暂无分享,去创建一个
Vineeth Rajkumar | D. Abraham | T. Krieg | V. Rajkumar | Beate Eckes | Thomas Krieg | B. Eckes | David J. Abraham
[1] T. Krieg,et al. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. , 2004, The American journal of pathology.
[2] G. Gabbiani,et al. The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.
[3] Holger Gerhardt,et al. Endothelial-pericyte interactions in angiogenesis , 2003, Cell and Tissue Research.
[4] D. Prockop. Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.
[5] E. Huberman,et al. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[6] V. Rajkumar,et al. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. , 1999, Arthritis and rheumatism.
[7] T. Krieg,et al. Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. , 1990, The Journal of clinical investigation.
[8] R. Kalluri,et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. , 2002, Kidney international.
[9] J. Korn,et al. Biology of the scleroderma fibroblast. , 1998, Current opinion in rheumatology.
[10] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[11] Vishal Kapoor,et al. Contribution of Bone Marrow–Derived Cells to Skin: Collagen Deposition and Wound Repair , 2004, Stem cells.
[12] J. Hagood,et al. Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. , 2007, American journal of respiratory cell and molecular biology.
[13] N. Wright,et al. Circulating mesenchymal stem cells. , 2004, The international journal of biochemistry & cell biology.
[14] Howard Y. Chang,et al. Anatomic Demarcation by Positional Variation in Fibroblast Gene Expression Programs , 2006, PLoS genetics.
[15] C. Heldin,et al. Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.
[16] T. Krieg,et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. , 2006, The journal of investigative dermatology. Symposium proceedings.
[17] E. Neilson. Mechanisms of Disease: fibroblasts—a new look at an old problem , 2006, Nature Clinical Practice Nephrology.
[18] Yunliang Chen,et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. , 2004, Molecular biology of the cell.
[19] H. Shigemitsu,et al. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis , 2004, Current opinion in rheumatology.
[20] P. Conget,et al. Mesenchymal Stem Cells , 2001, Experimental biology and medicine.
[21] G. Grove,et al. Human skin fibroblasts derived from papillary and reticular dermis: differences in growth potential in vitro. , 1979, Science.
[22] M. Landthaler,et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. , 2001, Arthritis and rheumatism.
[23] D. Abraham,et al. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse. , 2003, Arthritis and rheumatism.
[24] Andrew Leask,et al. All in the CCN family: essential matricellular signaling modulators emerge from the bunker , 2006, Journal of Cell Science.
[25] D. Sims. Diversity Within Pericytes , 2000, Clinical and experimental pharmacology & physiology.
[26] W. Paul,et al. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Andrew Leask,et al. TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] T. Yamamoto,et al. Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis. , 2001, Journal of dermatological science.
[29] R. Kalluri,et al. Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.
[30] M. Fujimoto,et al. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. , 1997, The Journal of rheumatology.
[31] T. Wright,et al. Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A , 1999 .
[32] J. Tomasek,et al. IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. , 2006, The Journal of investigative dermatology.
[33] J. Muddle,et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. , 2006, The American journal of pathology.
[34] M. Mayes,et al. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. , 2006, Arthritis and rheumatism.
[35] D. Abraham,et al. Mechanisms and consequences of fibrosis in systemic sclerosis , 2006, Nature Clinical Practice Rheumatology.
[36] A. Caplan,et al. Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.
[37] David Botstein,et al. Systemic and cell type-specific gene expression patterns in scleroderma skin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] Terry J. Smith,et al. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. , 2003, The American journal of pathology.
[39] B. Hinz,et al. Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.
[40] M. Salmon,et al. A stromal address code defined by fibroblasts. , 2005, Trends in immunology.
[41] Yunliang Chen,et al. Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. , 2002 .
[42] S. Phan,et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.
[43] K. Takabayashi,et al. Increased interleukin-17 production in patients with systemic sclerosis. , 2000, Arthritis and rheumatism.
[44] Y. Wu,et al. Intracellular IL-1 Receptor Antagonist Is Elevated in Human Dermal Fibroblasts That Overexpress Intracellular Precursor IL-1α , 1999, The Journal of Immunology.
[45] D. Abraham,et al. Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases. , 2005, Current vascular pharmacology.
[46] R. Puri,et al. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis , 2006, Nature Medicine.
[47] D. Pennington,et al. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. , 2000, Experimental cell research.
[48] K. Dittmann,et al. Human skin fibroblasts in vitro differentiate along a terminal cell lineage. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Mayes. Endothelin and endothelin receptor antagonists in systemic rheumatic disease. , 2003, Arthritis and rheumatism.
[50] U. Banning,et al. The Role of IL-4 and IL-12 in the Regulation of Collagen Synthesis by Fibroblasts , 2006, Immunological investigations.
[51] K. Rubin,et al. Pericytes as collagen-producing cells in excessive dermal scarring. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[52] A. Nicholson,et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.
[53] K. Csiszȧr,et al. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis , 2005, Arthritis research & therapy.
[54] B. White,et al. Immunopathogenesis of systemic sclerosis. , 1996, Rheumatic diseases clinics of North America.
[55] J. Korn,et al. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. , 2000, Arthritis and rheumatism.
[56] David Botstein,et al. Diversity, topographic differentiation, and positional memory in human fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[57] A. Geinoz,et al. The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, Journal of Cell Biology.
[58] Shawn Cowper,et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. , 2004, The international journal of biochemistry & cell biology.